Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: The axtell regimen
- C. F. Verschraegen
- , H. Arias-pulido
- , S. J. Lee
- , S. Movva
- , L. A. Cerilli
- , S. Eberhardt
- , B. Schmit
- , R. Quinn
- , C. Y. Muller
- , I. Rabinowitz
- , M. Purdy
- , D. Snyder
- , T. Bocklage
Research output: Contribution to journal › Article › peer-review
67
Link opens in a new tab
Scopus
citations